Seraflo (25 mcg+250 mcg)/puff (Inhaler)
60 metered doses: ৳ 430.00
Medicine Details
Category | Details |
---|---|
Generic | Salmeterol fluticasone propionate |
Company | Drug international ltd |
Also available as |
Indications
- Regular treatment of asthma
- Combination product (long-acting β2-agonist and inhaled corticosteroid) use
- Control of asthma not adequately managed with inhaled corticosteroids
- Control of asthma not managed with inhaled short acting β2-agonist
- Usual control on both inhaled corticosteroid and long-acting β2-agonist
Pharmacology
- Salmeterol Xinafoate - selective, long-acting beta-2 agonist
- Fluticasone Propionate - corticosteroid with glucocorticoid activity
- Topical effect on the lungs without systemic effects at usual dose
- Salmeterol protects against symptoms, Fluticasone Propionate improves lung function
- Convenient regime for patients on concurrent β-agonist and inhaled corticosteroid therapy
Dosage
- Adult and adolescent dosage
- Children dosage (4-12 years)
- Recommended starting dosages
- Maximum recommended dosage
- Use for asthma and COPD
- Maxhaler dosages for asthma
- Maxhaler dosages for COPD
Administration
- Steps for effective use of inhaler
- Instructions for cleaning inhaler
Interaction
- Avoid non-selective and selective β-blockers in patients with asthma
- Careful co-administration with strong CYP3A4 inhibitors
Contraindications
- Hypersensitivity to salmeterol xinafoate or fluticasone propionate
- Contraindicated in primary treatment of status asthmaticus
- Contraindicated in acute episodes of asthma with intensive measures
Side Effects
- Adverse reactions associated with Salmeterol and Fluticasone Propionate
- Pharmacological side effects of beta-2-agonist treatment
- Hoarseness, candidiasis, cutaneous hypersensitivity reactions
Pregnancy & Lactation
- Consideration of use during pregnancy
- Consideration of use in breast-feeding mothers
- Insufficient experience of use in human pregnancy and lactation
Precautions & Warnings
- Avoid initiation in patients during exacerbation of asthma
- Not for relief of acute symptoms
- Monitoring for serious asthma-related adverse events
- Treatment of paradoxical bronchospasm
- Increased reporting of pneumonia in COPD patients
- Systemic effects of inhaled corticosteroid
Use in Special Populations
- Potential reduction in growth velocity in pediatric patients
Overdose Effects
- Signs and symptoms of Salmeterol overdose
- Signs and symptoms of Fluticasone Propionate overdose
- Monitoring of adrenal reserve in cases of overdose
Therapeutic Class
- Long-acting selective β-adrenoceptor stimulants
- Respiratory corticosteroids
Storage Conditions
- Pressurised canister
- Avoid puncture, breaking or incineration
- Storage below 30°C
- Avoid sunlight, heat, and contact with eyes
- Keep away from children
Related Brands
- Aroflo (25 mcg+125 mcg)/puff (Inhaler) - aristopharma-ltd
- Aroflo (25 mcg+250 mcg)/puff (Inhaler) - aristopharma-ltd
- Arotide (25 mcg+125 mcg)/puff (Inhaler) - eskayef-pharmaceuticals-ltd
- Arotide (25 mcg+250 mcg)/puff (Inhaler) - eskayef-pharmaceuticals-ltd
- Bexitrol F (25 mcg+50 mcg)/puff (Inhaler) - beximco-pharmaceuticals-ltd